article
Why product information management is key to success in a changing pharma market
Mike Owen analyses how smart product information (PIM) management could be crucial in the future of pharma, given how large the industry continues to grow.
List view / Grid view
Baxter Healthcare
article
QA/QC & Analytical Techniques In-Depth Focus 2019 featuring Environmental Monitoring
This In-Depth Focus highlights why bio-fluorescent particle detection is an effective method for enumerating present microbes and discusses ICH Q10 knowledge management; presenting five tips for improving your company’s knowledge management.
article
Packaging In-Depth Focus 2017
FMD and supply chain security; Strategic aspects of change control for pharmaceutical packaging systems; and does the Falsified Medicines Directive lead to a European pack coding guideline?
news
Baxter BioScience acquires Oncaspar portfolio for leukaemia for $900m
Baxter has signed a definitive agreement to acquire the Oncaspar® (pegaspargase) product portfolio from Sigma-Tau for US $900 million.
article
RMM: In-Depth Focus 2014
Michael J. Miller discusses rapid microbiological methods and the regulatory environment, the Online Water Bioburden Analyzer Workgroup look at the path to implementing Online Water Bioburden Analyzers, plus RMM roundtable...
news
SAFC and Baxter BioPharma Solutions collaborate on complete ADC offering
24 September 2014 | By Sigma-Aldrich
Sigma-Aldrich Corporation’s SAFC® Commercial custom manufacturing services business unit, and Baxter’s BioPharma Solutions business have established a collaborative manufacturing agreement...
news
Baxter announces plans to create two separate global healthcare companies
28 March 2014 | By Baxter International Inc.
Baxter International Inc. has announced plans to create two separate, independent global healthcare companies – one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products...
news
Baxter achieves its first quarter expectations
19 April 2013 | By Baxter International Inc.
Baxter has reported first quarter financial results in line with the company's previously issued guidance...
article
Pharmaceutical Manufacturing & Packaging In-Depth Focus 2013
In this Pharmaceutical Manufacturing & Packaging In-Depth Focus: The chemical safety assessment process for extractables and leachables associated with packaged pharmaceutical products; INTERPHEX 2013: Show preview...
article
Rapid Methods supplement 2011
In this Rapid Methods supplement: A regulators view; Nucleic acid and gene amplification-based technologies; Challenges and strategies for application in the pharmaceutical industry...
news
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
article
Novel and emerging sterilisation technologies
9 October 2009 | By Dr Edward Tidswell, Senior Director of Sterility Assurance, Baxter Healthcare; Ash Khorzad, Sterile Manufacturing Support Group Manager and Mike Sadowski, Director of Sterile Product Manufacturing Support, Baxter Healthcare Corporation
The increasing number and diversity of traditional patient therapies, medical devices, and combinatorial products has created an increasing world-wide interest in the innovation of novel sterilisation technologies. In contrast to traditional moist heat sterilisation processes, emerging technologies are diverse, predominantly reliant on physical processes, involve multiple mechanisms of microbial inactivation…
